Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Formerly termed primary biliary cirrhosis, primary biliary cholangitis (PBC) is a chronic and progressive cholestatic liver disease characterized by the presence of antimitochondrial antibodies. Ursodeoxycholic acid (UDCA) therapy is the most effective and approved treatment for PBC and leads to a f...
Saved in:
Main Authors: | Satoru Joshita, Takeji Umemura, Eiji Tanaka, Masao Ota |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2017/3073504 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time to Make the Change from ‘Primary Biliary Cirrhosis’ to ‘Primary Biliary Cholangitis’
by: Angela C Cheung, et al.
Published: (2015-01-01) -
COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01) -
The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood
by: Priscila Menezes Ferri, et al.
Published: (2016-01-01) -
Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis
by: Xing-Chen Yang, et al.
Published: (2017-01-01) -
Rare renal proximal tubular dysfunctions in primary biliary cholangitis
by: Xiaoxiao Shi, et al.
Published: (2024-12-01)